Beta
Podcast cover art for: Measles is now endemic in the US. Here's how it erases immunity
Science Friday
Science Friday·18/11/2026

Measles is now endemic in the US. Here's how it erases immunity

This is a episode from podcasts.apple.com.
To find out more about the podcast go to Measles is now endemic in the US. Here's how it erases immunity.

Below is a short summary and detailed review of this podcast written by FutureFactual:

Measles No Longer Eliminated in the US: Outbreaks, Immunity, and the Path Forward

Summary

The Science Friday episode explains that PAHO has declared measles is no longer eliminated in the US, meaning outbreaks can persist longer than a year. The conversation explores what this implies for vaccination, surveillance, and hospital and school protections, and it situates the milestone in the context of declining vaccination rates and widespread misinformation. A second thread delves into immune amnesia, the way measles can erase immune memory, and how monoclonal antibodies might serve as a bridge to protection for the youngest and most vulnerable until they can be vaccinated. Together, the discussions emphasize that policy leadership and vaccination efforts must adapt to the new normal of measles transmission while new tools are developed to fill the protection gap.

  • Measles elimination defined by outbreak duration; its loss signals more persistent outbreaks
  • The role of vaccination uptake and misinformation in driving outbreaks
  • Immune amnesia: how measles can erase immune memory and affect susceptibility to other infections
  • Monoclonal antibodies as a potential interim protective strategy for vulnerable populations

Overview

The podcast discusses the Pan American Health Organization's recent determination that measles is no longer eliminated in the United States, a reframing of the country's measles risk landscape. Elimination is defined as outbreaks that do not persist for more than a year; since 2000, the US had not seen an outbreak last beyond that period, but recent events have exceeded it. Amy Maxman, national public health correspondent for KFF Health News, sets the stage by explaining that, while global eradication of measles remains unfinished, the current status means occasional, long-lasting outbreaks are possible in the US as vaccination rates dip and exposure occurs across borders. The host emphasizes that this is not a sudden collapse but a milestone that signals the need for renewed public health action to boost vaccination coverage and surveillance. The discussion also touches on historical outbreaks and how leadership responded in the past, including congressional hearings during outbreaks in 2014-2015 and 2019 that led to vaccine access policies.

What Elimination Means in Practice

The main point of the elimination concept is that outbreaks should burn out if the population is well protected by vaccines. Once outbreaks persist beyond a year, the dynamics of transmission shift, and hospital and school systems must adjust. The episode highlights that measles is among the most contagious viruses we know, capable of spreading through adjacent rooms and into vulnerable populations such as infants and the immunocompromised. The practical implications include heightened vigilance in health care settings, enhanced infection prevention, and robust vaccination clinics. The program notes that while the federal response may not yet have formally changed course, PAHO recommendations typically involve accelerating vaccination campaigns, improving surveillance, and tracing exposures to curb broader spread.

The Policy and Public Health Context

The guests discuss how last year featured outbreaks that had been underway for more than a year, including one in Utah with roots linked to earlier West Texas outbreaks. The conversation contrasts this with earlier eras when federal leadership and cross-partisan oversight—such as vaccine accessibility and school-based vaccination requirements—helped to blunt transmission. The speakers reflect on the political reality in the United States, where public health messaging can become disputed terrain, complicating the adoption of strategic vaccination policies. They note that during prior outbreaks, political leaders and health agencies were held to account and acted to expand immunization and clinic access. The current moment remains uncertain, but it is presented as a potential turning point that could mobilize better leadership and targeted public health investments.

Immune Amnesia and New Therapeutics

The episode then shifts to the immune memory implications of measles, a topic explored in depth with Dr. Michael Mina. The measles virus uses the CD150 (SLAM) receptor to infect immune memory cells, effectively erasing immunological memories of previous infections and vaccines. This process can leave children and adults more susceptible to other infections for two to three years after measles infection—a phenomenon researchers describe as immune amnesia, not immune suppression. The discussion explains how this renewal of vulnerability can drive a higher disease burden in the aftermath of a measles outbreak, reinforcing the importance of maintaining high vaccination rates to protect immune memory in the population. The concept of an immunological reset is described through the idea that while memory can be rebuilt via vaccination and exposure, the window of heightened risk is real and consequential.

Monoclonal Antibody as a Bridge

Dr. Mina also discusses monoclonal antibodies as a form of passive immunization that could offer protection for a year or two from a single shot. This approach would be especially valuable for bridging the protection gap for newborns or children who cannot yet receive vaccines, as well as for other high-risk groups. The discussion covers the practical steps toward clinical testing, with the team aiming to start first-in-human studies within six months. The monoclonal antibody candidate has shown promise in laboratory settings, and researchers are working to establish safety and efficacy in human trials. While monoclonal antibodies do not create long-term immune memory, their potential to extend maternal and early-life protection could be a critical tool in reducing measles-related morbidity and mortality while vaccination coverage improves.

What Needs to Change Next

The final sections reflect on the role of Congress and leadership in shaping the public health response to measles outbreaks, recalling past periods when lawmakers and health agencies acted decisively to expand vaccine access after major outbreaks. The experts emphasize that this moment should be treated as a call to action: to increase vaccination clinics, strengthen surveillance, and combat misinformation with a clear, evidence-based voice. They also acknowledge that the dynamics of public opinion and policy will influence how effectively responses can be scaled, and they call for sustained political will to support immunization programs and the development of useful tools like monoclonal antibodies to bridge the protection gap until elimination or eradication is achieved globally.

Conclusion

Overall, the podcast frames the PAHO decision as a turning point that requires pragmatic public health action and new biomedical tools. It underscores that measles remains highly transmissible and that maintaining high vaccination rates is essential to protecting immune memory on a broad scale. The discussion about immune amnesia and monoclonal antibodies adds a forward-looking dimension to measles policy, highlighting the potential for innovative interventions to complement traditional vaccination strategies as the public health community reaffirms its commitment to preventing outbreaks and protecting vulnerable populations.

Related posts

featured
National Public Radio
·23/09/2026

Vaccinated or not, we’re on the brink of a measles epidemic

featured
Scientific American
·08/04/2026

U.S. measles cases surge as vaccination rates drop

featured
Rhys James, James Tytko, Will Tingle
·08/04/2025

Why are measles cases surging?

featured
The Conversation UK
·16/10/2026

Vaccines have been so successful that some people have forgotten why we need them